203 related articles for article (PubMed ID: 29321566)
1. N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.
Kugaevskaya EV; Veselovsky AV; Indeykina MI; Solovyeva NI; Zharkova MS; Popov IA; Nikolaev EN; Mantsyzov AB; Makarov AA; Kozin SA
Sci Rep; 2018 Jan; 8(1):298. PubMed ID: 29321566
[TBL] [Abstract][Full Text] [Related]
2. Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.
Larmuth KM; Masuyer G; Douglas RG; Schwager SL; Acharya KR; Sturrock ED
FEBS J; 2016 Mar; 283(6):1060-76. PubMed ID: 26748546
[TBL] [Abstract][Full Text] [Related]
3. The N-domain of angiotensin-converting enzyme specifically hydrolyzes the Arg-5-His-6 bond of Alzheimer's Abeta-(1-16) peptide and its isoAsp-7 analogue with different efficiency as evidenced by quantitative matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Toropygin IY; Kugaevskaya EV; Mirgorodskaya OA; Elisseeva YE; Kozmin YP; Popov IA; Nikolaev EN; Makarov AA; Kozin SA
Rapid Commun Mass Spectrom; 2008; 22(2):231-9. PubMed ID: 18085519
[TBL] [Abstract][Full Text] [Related]
4. Zinc-induced heterodimer formation between metal-binding domains of intact and naturally modified amyloid-beta species: implication to amyloid seeding in Alzheimer's disease?
Mezentsev YV; Medvedev AE; Kechko OI; Makarov AA; Ivanov AS; Mantsyzov AB; Kozin SA
J Biomol Struct Dyn; 2016 Nov; 34(11):2317-26. PubMed ID: 26513486
[TBL] [Abstract][Full Text] [Related]
5. [Angiotensin converting enzyme: the antigenic properties of the domain, role in Alzheimer's disease and tumor progression].
Kugaevskaya EV; Timoshenko OS; Solovyeva NI
Biomed Khim; 2015; 61(3):301-11. PubMed ID: 26215407
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a possible role of Stigmatella aurantiaca ACE in Aβ peptide degradation: a molecular modeling approach.
Jalkute CB; Sonawane KD
J Mol Microbiol Biotechnol; 2015; 25(1):26-36. PubMed ID: 25677850
[TBL] [Abstract][Full Text] [Related]
7. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
Chen PT; Chen CL; Lin LT; Lo CH; Hu CJ; Chen RP; Wang SS
PLoS One; 2016; 11(4):e0153360. PubMed ID: 27096746
[TBL] [Abstract][Full Text] [Related]
8. [Angiotensin converting enzyme and Alzheimer's disease].
Kugaevskaia EV
Biomed Khim; 2013; 59(1):5-24. PubMed ID: 23650720
[TBL] [Abstract][Full Text] [Related]
9. Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides.
Sun X; Becker M; Pankow K; Krause E; Ringling M; Beyermann M; Maul B; Walther T; Siems WE
Eur J Pharmacol; 2008 Jun; 588(1):18-25. PubMed ID: 18495113
[TBL] [Abstract][Full Text] [Related]
10. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
[TBL] [Abstract][Full Text] [Related]
11. Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme.
Medvedev AE; Radko SP; Yurinskaya MM; Vinokurov MG; Buneeva OA; Kopylov AT; Kozin SA; Mitkevich VA; Makarov AA
J Alzheimers Dis; 2018; 66(1):263-270. PubMed ID: 30282362
[TBL] [Abstract][Full Text] [Related]
12. [Enalaprilat Inhibits Zinc-Dependent Oligomerization of Metal-Binding Domain of Amyloid-beta Isoforms and Protects Human Neuroblastoma Cells from Toxic Action of these Isoforms].
Kozin SA; Polshakov VI; Mezentsev YV; Ivanov AS; Zhokhov SS; Yurinskaya MM; Vinokurov MG; Makarov AA; Mitkevich VA
Mol Biol (Mosk); 2018; 52(4):683-691. PubMed ID: 30113034
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
Zou K; Yamaguchi H; Akatsu H; Sakamoto T; Ko M; Mizoguchi K; Gong JS; Yu W; Yamamoto T; Kosaka K; Yanagisawa K; Michikawa M
J Neurosci; 2007 Aug; 27(32):8628-35. PubMed ID: 17687040
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide.
Jalkute CB; Barage SH; Dhanavade MJ; Sonawane KD
Protein J; 2013 Jun; 32(5):356-64. PubMed ID: 23660814
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.
Bernstein KE; Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Lopes DH; Shah KH; Bernstein EA; Fuchs DT; Yu JJ; Pham M; Black KL; Shen XZ; Fuchs S; Koronyo-Hamaoui M
J Clin Invest; 2014 Mar; 124(3):1000-12. PubMed ID: 24487585
[TBL] [Abstract][Full Text] [Related]
16. Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.
Hemming ML; Selkoe DJ; Farris W
Neurobiol Dis; 2007 Apr; 26(1):273-81. PubMed ID: 17321748
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.
Hu J; Igarashi A; Kamata M; Nakagawa H
J Biol Chem; 2001 Dec; 276(51):47863-8. PubMed ID: 11604391
[TBL] [Abstract][Full Text] [Related]
18. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
[TBL] [Abstract][Full Text] [Related]
19. [Identification of the minimal zinc-binding center in natural isoforms of amyloid-beta domain 1-16 using ESI-MS].
Popov IA; Indeĭkina MI; Kononikhin AS; Starodubtseva NL; Kozin SA; Makarov AA; Nikolaev EN
Mol Biol (Mosk); 2013; 47(3):498-504. PubMed ID: 23888782
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
Hemming ML; Selkoe DJ
J Biol Chem; 2005 Nov; 280(45):37644-50. PubMed ID: 16154999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]